Skip to: Content
Skip to: Site Navigation
Skip to: Search

May 17, 2008 12:48:29 AM CDT

Learn about Newser Points »

Back to the grid

FDA Probes Suicide Link to Asthma Drug  

Posted Mar 28, 08 7:09 AM CDT in Science & Health    Most Covered

(newser) – The FDA has opened an investigation of anecdotal links between the popular asthma and allergy drug Singulair and suicidal thoughts. In the past year, manufacturer Merck has added warnings of several possible side effects of  the pill related to the nervous system, including anxiety, depression, tremors, and suicidal thinking. The FDA says its review of the drug, which had sales of more than $4.3 billion last year, may take up to nine months.

Merck received reports "from physicians, patients and parents or relatives" concerning the drug, which has been used by "millions" of people, said a company official. The review "does not mean that FDA has concluded there is a causal relationship,” said an FDA statement. Related drugs such as Accolate and Zyflo will also be studied for possible links to mood or suicide disorders.

Source USA Today

open commentscomments (0)

Editor Recommended

Merck cooperating with FDA in investigation
WebMD | Mar 27, 08

Related News

  • FDA Mandates Suicide Risk Assessment in Drug Trials

    Jan 24, 08 11:42 AM CST
    FDA Mandates Suicide Risk Assessment in Drug Trials The Food and Drug Administration is now requiring drug companies to monitor suicide warning signs in clinical trials for experimental drugs, the New York Times reports. In the wake of studies showing that antidepressants might increase the risk of self-harm in children and teens, the agency is showing an awareness that a surprising variety of drugs can have psychiatric effects. More »

FDA Probes Suicide Link to Asthma Drug
Merck & Co. provided this Oct. 10, 1999 photo of their Whitehouse Station, N.J. corporate headquarters.   (AP Photo)
FDA Probes Suicide Link to Asthma Drug
In this undated photo released by German drug maker Merck & Co., an employee controls samples in the molecular biology department. The FDA is investigating the allergy drug Singulair.   (AP Photo/Merck)
FDA Probes Suicide Link to Asthma Drug
An employee walks past a stained-glass window at Merck & Co.'s headquarters in Whitehouse Station, N.J. in this Sept. 30, 2004 file photo.   (AP Photo/Daniel Hulshizer, file)
prev   next
play

Threads (1 of 2)

Tags

FDA  • suicide  • Merck  • asthma  • allergy  • Singulair


Loading...

Loading...

Related Threads: Drug Companies, Food & Drug Safety

Next story from this section »

Today's Most Popular

Loading...

Other Science & Health Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »